KfW

KfW operates as the promotional bank of the Federal Republic of Germany, headquartered in Frankfurt. Established in 1948, KfW focuses on fostering economic, social, and ecological development both domestically and internationally. The bank offers a variety of financial services and support, particularly in the areas of small and medium-sized enterprises, environmental protection, housing, infrastructure, and education finance. It engages in financing corporate investments, industrial pollution control projects, and export activities, while also providing advisory services and equity financing. Additionally, KfW funds the promotional institutions of the federal states and promotes development in emerging economies on behalf of the federal government. The bank actively participates in securities and money market investments and holds arrangements for the Federal Republic, playing a significant role as a socially responsible investor in the international capital market.

Jochen Eichmann

Head of Venture Tech Growth Financing (VTGF)

Hansgeorg Rasch

CEO

174 past transactions

Polygenta Technologies

Debt Financing in 2022
Polygenta Technologies Limited is a prominent manufacturer of Polyester Filament Yarn (PFY) based in Mumbai, India. The company utilizes recycled post-consumer PET bottles as its primary feedstock, converting approximately 1.5 million bottles daily at its plant in Nashik, resulting in an annual production of around 10,000 metric tons of sustainable premium yarn. Polygenta offers a range of products, including drawn texturized and partially oriented yarns, as well as polyester chips, which are used in various applications such as sports apparel, women's clothing, denim, casual wear, uniforms, furnishings, luggage, and automotive fabrics. Established in 1981 and originally known as Maskara Industries Ltd., the company rebranded to Polygenta Technologies Limited in June 2001. It operates as a subsidiary of PerPETual Global Technologies Ltd.

Electrochaea

Series D in 2022
Electrochaea GmbH develops and commercializes a grid-scale power-to-gas energy storage technology. The company’s biocatalytic power-to-gas technology converts low-cost and stranded electricity into pipeline-grade renewable gas for direct injection into the existing natural gas grid, which is used for on-site power production, heating applications, or transmitted over long distances using existing pipelines. Its technology enables storing large amounts of renewable energy from wind and solar; and represents a solution for utility-scale energy storage, grid balancing, and carbon recycling. Electrochaea GmbH was founded in 2010 and is based in Planegg, Germany with additional operation facilities at Hvidovre, Denmark, and Sacramento, California.

Uniper

Post in 2022
Uniper is an international energy company with about 11,000 employees. They combine a balanced portfolio of technologically advanced large-scale assets with outstanding technical and commercial expertise. Uniper is a German energy company based in Dusseldorf, North Rhine-Westphalia. It was formed by the separation of E.ON's fossil fuel assets into a separate company that began operating on 1 January 2016.

NamPower

Grant in 2021
NamPower is the national power utility of Namibia and specializes in the generation and transmission of electricity.
The InsuResilience Investment Fund, formerly known as Climate Insurance Fund, is an initiative created by KfW, the German Development Bank, on behalf of the German Ministry for Economic Cooperation and Development (BMZ). The overall objective of the InsuResilience Investment Fund is to contribute to the adaptation to climate change by improving access to and the use of insurance in developing countries. The specific objective of the fund is to reduce the vulnerability of micro, small and medium enterprises (MSME) as well as low-income households to extreme weather events.

Electrochaea

Venture Round in 2021
Electrochaea GmbH develops and commercializes a grid-scale power-to-gas energy storage technology. The company’s biocatalytic power-to-gas technology converts low-cost and stranded electricity into pipeline-grade renewable gas for direct injection into the existing natural gas grid, which is used for on-site power production, heating applications, or transmitted over long distances using existing pipelines. Its technology enables storing large amounts of renewable energy from wind and solar; and represents a solution for utility-scale energy storage, grid balancing, and carbon recycling. Electrochaea GmbH was founded in 2010 and is based in Planegg, Germany with additional operation facilities at Hvidovre, Denmark, and Sacramento, California.

Productsup

Debt Financing in 2021
Productsup provides an intuitive SaaS for product content integration, optimization and distribution in commerce. Offering a range of solutions like feed management, marketplace integration, seller / vendor onboarding and product content syndication, Productsup helps brands and retailers validate, structure and enrich their product content for thousands of retail and digital channels, including Amazon, Walmart, Google and Facebook. With agile data and seamless connectivity, Productsup customers can get their products to market faster, scale their business and capture new opportunities as they happen. The cloud-based software is trusted by more than 800 companies worldwide, including 5 of the Fortune 20, as well as market leaders like IKEA, Walmart, Superdry and Rakuten.

GetYourGuide

Debt Financing in 2021
GetYourGuide Deutschland GmbH is an online platform that facilitates the booking of tours, attractions, and activities globally. Founded in 2009 and headquartered in Berlin, Germany, the company operates additional offices in North America and Europe. GetYourGuide serves as a mediator between customers and service providers, offering a wide range of options, including cooking classes and tickets to popular tourist sites, without directly offering its own tours. The platform allows users to book experiences such as skip-the-line tickets and last-minute activities, enhancing the travel experience. Customers can access services for free, while providers pay a percentage of their revenue to GetYourGuide. The platform features a customer review system, which helps users evaluate the quality of tour providers, and it removes those who receive consistently poor reviews from its offerings.

Cleverciti

Series A in 2020
Cleverciti Systems GmbH specializes in developing smart parking solutions that aim to optimize outdoor parking operations. Founded in 2012 by Thomas Hohenacker, the company is headquartered in Munich, Germany, with additional offices in Chicago. Cleverciti offers a comprehensive platform that includes Cleverciti SENSORS, which detect and locate free and occupied parking spaces in real time, and the Cleverciti APP, which guides drivers to available spaces, thereby minimizing search time and traffic congestion. Additionally, the Cleverciti COCKPIT serves as a back-office interface, providing users with monitoring and control features. By integrating intelligent parking detection with driver communication, Cleverciti enhances data capture and analysis across various organizational divisions. Its solutions have been deployed in diverse sectors such as retail, smart city initiatives, healthcare, and entertainment, all aimed at reducing vehicle emissions, traffic, and improving overall parking management.

EFTA

Venture Round in 2020
EFTA Ltd operates as a finance company in Tanzania. It offers equipment loans comprising standard equipment loans; loans for moveable equipment; repeat loans for customers who have completed a loan previously; loans for customers seeking to import equipment from India, Kenya, or China; loans for customers enrolled in or seeking to enroll in Safecare; and low interest rate loans offered through preferred suppliers. The company also provides larger leases for agricultural loans for agri-businesses or farmers. It serves small and medium enterprises, and farmers. The company was founded in 2003 and is headquartered in Moshi, Tanzania with an additional branch in Dar es Salaam, Tanzania.

kraftwerk Inc.

Convertible Note in 2020
Kraftwerk Inc. specializes in the production of innovative energy solutions through its proprietary technology, which converts various fuels, including natural gas, liquefied gas, gasoline, and kerosene, into electricity. The company's key product, the kraftwerk TUBE, is a nanocoated metallic tube designed for compact fuel cell applications. These tubes enable the development of lightweight and highly efficient energy sources suitable for mobile applications in automotive and aerial vehicles. By directly transforming fuels into electricity, Kraftwerk Inc. aims to enhance energy efficiency and promote the use of cleaner energy systems in various industries.

CureVac

Venture Round in 2020
CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA. The company develops drugs that are based on Messenger RNA (mRNA) as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. mRNA programs include novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases (RNActive), molecular therapies designed to trigger the body’s own production of therapeutic proteins (RNArt), and RNA encoded antibodies (RNAntibody). Its most advanced product candidate, CV9104, is being developed in Phase IIb for the treatment of prostate cancer.

Adidas

Post in 2020
Adidas AG, founded in 1949 and headquartered in Herzogenaurach, Germany, designs, develops, produces, and markets a wide range of athletic and lifestyle products globally. The company operates across various segments, including Europe, North America, Asia-Pacific, and Latin America, and offers footwear, apparel, and sports equipment under its adidas and Reebok brands. Its diverse product portfolio encompasses offerings for professional athletes, casual activewear, and fashion items, allowing it to meet varied consumer needs and mitigate market risks. Adidas also manages the digital health and fitness platform Runtastic and the Y-3 label. The company distributes its products through approximately 1,900 owned retail stores, 15,000 franchise stores, and 150,000 wholesale locations, in addition to its e-commerce channel, which serves 67 countries. With a commitment to excellence in key segments such as football, running, training, basketball, and Originals, Adidas aims to solidify its position as a leading global sports brand.

GNA Biosolutions

Series C in 2019
GNA Biosolutions is a molecular technology company located in Martinsried, Germany, specializing in innovative diagnostic devices for detecting and analyzing DNA. Their core technology, Pulse Controlled Amplification, enhances molecular testing by integrating ultrafast nucleic acid amplification with intrinsic sample preparation. This advancement allows for efficient and simplified diagnosis of human pathogens in laboratory settings, as well as on-site applications and Point of Care scenarios. GNA Biosolutions aims to make the benefits of molecular testing accessible to a broader audience, facilitating rapid and accurate results from sample collection to analysis.

OMEICOS Therapeutics

Series C in 2018
OMEICOS Therapeutics GmbH is a biotechnology company focused on developing innovative therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases. Established in 2013 and headquartered in Berlin, Germany, the company is pioneering a first-in-class small molecule that leverages a unique mode of action based on natural metabolites of omega-3 fatty acids. These metabolites exhibit strong anti-arrhythmic properties by activating an endogenous cardio-protective signaling pathway, which not only stabilizes heart rhythm but also aims to provide curative effects by preventing electrical and structural remodeling of the heart. OMEICOS' approach is designed to offer safe and effective treatment options for patients with cardiovascular conditions, while also addressing inflammatory diseases and other indications.

Pflege.de

Venture Round in 2018
pflege.de, operated by web care LBJ GmbH, is an online portal that provides comprehensive information and resources related to elderly care and housing services in Germany. Founded in 2011 and headquartered in Hamburg, the platform connects users with various health care operators and service providers, offering a diverse range of services. These include nursing and residential care, aids for seniors such as walking and hearing aids, and supportive services like meal delivery and companionship. Additionally, pflege.de emphasizes accessibility by providing solutions like bathroom modifications and stair lifts. The company also offers emergency solutions, including carephones and mobile applications tailored to the needs of the elderly. Through its extensive network of partners, pflege.de aims to deliver holistic care options, ensuring that seniors receive the support they need in both domestic and institutional settings.

Veact

Series B in 2018
VEACT GmbH, founded in 2010 and based in Munich, Germany, specializes in providing software-as-a-service solutions for after-sales marketing in the automotive industry. The company has developed a platform that digitizes marketing processes, utilizing self-learning technology and extensive automobile expertise. By integrating various data sources, such as invoices, service histories, satisfaction surveys, and campaign data, VEACT creates comprehensive customer profiles. This approach allows automotive dealerships and manufacturers to enhance their marketing and sales processes, leading to improved efficiency, reduced costs, and increased customer loyalty. Ultimately, VEACT's services aim to boost revenue for its clients through data-driven insights and predictive customer intelligence.

Eskom Holdings

Debt Financing in 2018
Eskom Holdings SOC Ltd is a key player in the electricity sector of South Africa, generating approximately 95% of the country's electricity and around 45% of the electricity consumed in Africa. The company, founded in 1923 and headquartered in Sandton, operates through various segments including Generation, Transmission, and Distribution. It provides electricity to a diverse range of customers, including industrial, mining, commercial, agricultural, and residential sectors. Eskom utilizes multiple energy sources such as coal, nuclear, wind, hydro, and gas turbines for power generation and also engages in electricity trading with countries in the Southern African Development Community (SADC). The company is involved in constructing additional power infrastructure to meet increasing demand and has a service concession for electricity generation and transmission in Uganda. Beyond its core operations, Eskom engages in finance, insurance, corporate social investment, and coal exports, contributing to its broad business portfolio.
IL&FS Transportation Networks Limited, established in 2000 and based in Mumbai, India, specializes in the development and operation of surface transportation infrastructure projects both domestically and internationally. As a subsidiary of Infrastructure Leasing & Financial Services Limited, the company has established itself as a leader in the transportation sector, managing around 13,100 lane kilometers of road assets. Its portfolio includes the construction and maintenance of highways, bridges, flyovers, metro rail systems, city bus services, and border check posts. The firm also provides toll collection and operation services for toll road projects. In addition to its extensive domestic operations, IL&FS Transportation has expanded its reach internationally, with interests in countries such as Spain, Portugal, and Latin America through the acquisition of Elsamex S.A., a company focused on highway operations and maintenance.

advanceCOR

Venture Round in 2018
advanceCOR GmbH is a drug development company based in Munich, Germany, specializing in therapeutics and diagnostics for heart and vascular diseases. Founded in 2000, the company focuses on creating personalized treatments and has developed several innovative products. Notable among these is Revacept, a human Fc fusion protein that inhibits the local activation of platelets at vascular injury sites. Additionally, advanceCOR offers COR-2, a recombinant protein that reduces foam cell generation and cholesterol uptake, and COR-3, which targets atherosclerotic plaques while binding to progenitor cells to promote plaque healing. The company’s product pipeline also includes therapies for acute arterial thrombosis, myocardial infarction, stroke, and transient ischemic attack, emphasizing its commitment to addressing serious cardiovascular conditions.

Acousia Therapeutics

Series B in 2018
Acousia Therapeutics GmbH is a biotech company based in Tübingen, Germany, founded in 2012. It focuses on developing small molecule drugs aimed at treating hearing loss through local application. The company's innovative approach targets the regeneration of sensory hair cells in the inner ear, which are essential for hearing. By stimulating cellular regeneration from supporting cells, Acousia's therapies aim to restore hearing in patients affected by various conditions, including noise trauma, ototoxic drug treatment, and sudden deafness. Additionally, its research and development efforts are directed towards addressing age-related hearing decline.
Implandata Ophthalmic Products GmbH is a medical device company based in Hanover, Germany, specializing in innovative solutions for the treatment and management of glaucoma. Founded in 2010, the company has developed the Eyemate system, which features an implantable micro sensor designed for continuous intraocular pressure measurement. This technology aims to enhance the monitoring and therapy of glaucoma patients, providing eye care specialists with proactive and personalized guidance in treatment. By integrating advanced medical technology with information systems, Implandata addresses an underserved area in glaucoma care, facilitating more effective management for patients, their families, and healthcare providers.

Hemovent

Series A in 2017
Hemovent, based in Aachen, Germany, is a privately held medical technology company focused on developing a portable ECMO (Extracorporeal Membrane Oxygenation) unit. Founded by Christof Lenz and Oliver Marseille, the company aims to create an innovative device that supports or replaces heart and lung functions in cases of cardiac or respiratory failure. Hemovent's portable unit provides critical respiratory support for patients whose lungs are severely compromised, acting as a temporary life support system that takes over heart function during acute heart failure. This technology allows hospitals to stabilize patients and address the underlying issues leading to the failure while enabling patient mobility, thereby enhancing treatment options and outcomes.

BigRep

Series B in 2017
BigRep is a technology start-up based in Berlin with offices in New York, Boston and Singapore, which develops and manufactures the world's largest 3-D printers. One of the groundbreaking developments of the company founded in 2014 is the BigRep ONE, which is supplemented by the smaller BigRep STUDIO. Interdisciplinary and well-founded experience in the field of additive manufacturing characterizes the multi-national team of BigRep, now more than 80 employees. In addition to new products, the Berlin company is now concentrating on complete solutions for industrial customers in the form of integrated additive manufacturing systems. Over the next five years, BigRep intends to become a leading supplier of additive manufacturing systems.

nello

Seed Round in 2017
Nello is a technology company focused on simplifying urban living through innovative solutions. It develops a smart intercom system that upgrades existing intercom units in multi-family homes, allowing residents to control access remotely via their smartphones. This keyless entry system facilitates efficient and secure access for visitors and delivery services, promoting unattended deliveries and pickups. By enhancing the functionality of traditional intercoms, nello aims to streamline logistics and improve convenience for urban dwellers.

OMEICOS Therapeutics

Series B in 2017
OMEICOS Therapeutics GmbH is a biotechnology company focused on developing innovative therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases. Established in 2013 and headquartered in Berlin, Germany, the company is pioneering a first-in-class small molecule that leverages a unique mode of action based on natural metabolites of omega-3 fatty acids. These metabolites exhibit strong anti-arrhythmic properties by activating an endogenous cardio-protective signaling pathway, which not only stabilizes heart rhythm but also aims to provide curative effects by preventing electrical and structural remodeling of the heart. OMEICOS' approach is designed to offer safe and effective treatment options for patients with cardiovascular conditions, while also addressing inflammatory diseases and other indications.

smartB

Series A in 2017
smartB Energy Management GmbH, founded in 2014 and based in Berlin, Germany, specializes in software-based energy metering and monitoring solutions for commercial buildings. The company employs advanced non-intrusive technologies and algorithms to provide a comprehensive appliance load monitoring system. By enhancing the transparency of energy usage, smartB enables clients to achieve significant improvements in energy efficiency. Recognizing that commercial buildings consume a substantial portion of the world's energy—accounting for 30% of operational costs—smartB aims to transform sustainability into economic benefits for its customers. Through its innovative approach, the company seeks to challenge the conventional methods of energy management and drive meaningful change within the sector.

Amcure

Series B in 2016
amcure GmbH is a clinical-stage biopharmaceutical company based in Eggenstein-Leopoldshafen, Germany, focused on the research and development of peptide-based compounds designed to treat highly metastatic forms of squamous cancer. Founded in 2011 as a spin-off from the Karlsruhe Institute of Technology, amcure is dedicated to targeting the tumor-specific co-receptor CD44v6, which plays a critical role in activating various receptor tyrosine kinase pathways. Their lead candidate, AM001, effectively inhibits pathways associated with vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), providing a novel therapeutic approach to combat metastatic tumors. The company has advanced its first-in-class CD44v6 inhibitor, AMC303, into clinical development for solid tumors as of late 2016, aiming to improve treatment options for cancers such as pancreatic, head and neck, gastric, colorectal, breast, and lung cancer.

Acousia Therapeutics

Series A in 2016
Acousia Therapeutics GmbH is a biotech company based in Tübingen, Germany, founded in 2012. It focuses on developing small molecule drugs aimed at treating hearing loss through local application. The company's innovative approach targets the regeneration of sensory hair cells in the inner ear, which are essential for hearing. By stimulating cellular regeneration from supporting cells, Acousia's therapies aim to restore hearing in patients affected by various conditions, including noise trauma, ototoxic drug treatment, and sudden deafness. Additionally, its research and development efforts are directed towards addressing age-related hearing decline.

DiGiConsul

Debt Financing in 2016
Journey is a revolutionary consulate management platform. A modular GovTech (eGovernment) platform, we bring technological advances to consular processes, enhancing consular officer judgement and improving the first line of defence in border security.

Arzneimittelwerk Warngau

Series C in 2016
Arzneimittelwerk Warngau is a pharmaceutical company based in Warngau, Germany, specializing in the development and manufacturing of innovative drug delivery systems. Founded in 2008 by Wilfried Fischer, the company focuses on creating therapeutic solutions primarily in the fields of oncology, pain therapy, and neurology. Its product portfolio includes active ingredient and biodegradable implants, as well as transdermal systems, featuring both passive and microchip-controlled patches. Through its commitment to advancing drug delivery technologies, Arzneimittelwerk Warngau aims to improve patient outcomes in various therapeutic areas.

CryoTherapeutics

Series B in 2016
CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intends to extend the benefits of cryoenergy to the problem of diseased coronary arteries.

fromAtoB

Series A in 2016
fromAtoB GmbH is a travel search engine based in Munich, Germany, founded in 2008. The platform specializes in comparing and combining various modes of transportation, including trains, flights, ride-sharing, long-distance buses, taxis, rental cars, and public transport. It integrates a wide range of mobility providers, allowing users to easily plan their journeys, compare travel options, and book transportation securely. The service aims to facilitate better travel experiences by offering comprehensive deals and information for users traveling within Europe, North America, and globally.

Unidesq

Seed Round in 2016
Unidesq is a programmatic advertising company based in Cologne-Ehrenfeld that offers a comprehensive platform for global brands to manage their advertising needs. The company provides online advertising services designed to enhance brand awareness and drive sales through innovative and data-driven strategies. By utilizing a single user interface, Unidesq enables clients to execute digital advertising campaigns that foster sustainable connections with consumers. Their approach emphasizes transparency and independence, ensuring that brands can rely on data, insights, and personalized communication to reach their target audiences effectively.

nello

Seed Round in 2016
Nello is a technology company focused on simplifying urban living through innovative solutions. It develops a smart intercom system that upgrades existing intercom units in multi-family homes, allowing residents to control access remotely via their smartphones. This keyless entry system facilitates efficient and secure access for visitors and delivery services, promoting unattended deliveries and pickups. By enhancing the functionality of traditional intercoms, nello aims to streamline logistics and improve convenience for urban dwellers.

Readfy

Seed Round in 2016
Readfy GmbH is a digital reading platform based in Düsseldorf, Germany, founded in 2013. It offers users the ability to read e-books across a wide range of genres, including classical literature, crime, science fiction, romance, non-fiction, and more. The platform supports various languages, catering to a diverse audience. Readfy is designed to provide a social reading experience, allowing users to engage with digital content in an innovative way. By combining a vast selection of books with the convenience of mobile access, Readfy seeks to transform the reading experience in the evolving publishing industry.

Hemovent

Series A in 2016
Hemovent, based in Aachen, Germany, is a privately held medical technology company focused on developing a portable ECMO (Extracorporeal Membrane Oxygenation) unit. Founded by Christof Lenz and Oliver Marseille, the company aims to create an innovative device that supports or replaces heart and lung functions in cases of cardiac or respiratory failure. Hemovent's portable unit provides critical respiratory support for patients whose lungs are severely compromised, acting as a temporary life support system that takes over heart function during acute heart failure. This technology allows hospitals to stabilize patients and address the underlying issues leading to the failure while enabling patient mobility, thereby enhancing treatment options and outcomes.

Trinckle

Seed Round in 2015
trinckle 3D GmbH owns and operates a three-dimensional (3D) print service, marketplace, and design community Website. Its Website enables the users to upload, 3D print, and/or sell designs; buy 3D printed designs; and find a 3D designer. The company’s Website also provides 3D printing services for three-dimensional objects in the areas of architecture and famous buildings, art and decoration, consumer goods, historical, hobby and activities, home/office and garden, jewelry and clothing, music, nature and environment, persons, science, transportation and technology, and others. trinckle 3D GmbH was founded in 2013 and is based in Berlin, Germany.

meventi Deutschland

Venture Round in 2015
meventi Deutschland GmbH is a Munich-based company that specializes in advertising and distributing experience gifts and gift ideas for a diverse range of customers, including individuals, couples, and groups. Established in 2007, the company offers a variety of experiences, such as short breaks, helicopter flights, parachute jumps, Ferrari tours, igloo nights, and unique dining experiences like "dinner in the dark." Products are available through its website, a multi-tiered partner program, and integration into customer loyalty systems. In addition to its headquarters in Munich, meventi Deutschland also has branch offices in Sweden.

Cleverciti

Seed Round in 2015
Cleverciti Systems GmbH specializes in developing smart parking solutions that aim to optimize outdoor parking operations. Founded in 2012 by Thomas Hohenacker, the company is headquartered in Munich, Germany, with additional offices in Chicago. Cleverciti offers a comprehensive platform that includes Cleverciti SENSORS, which detect and locate free and occupied parking spaces in real time, and the Cleverciti APP, which guides drivers to available spaces, thereby minimizing search time and traffic congestion. Additionally, the Cleverciti COCKPIT serves as a back-office interface, providing users with monitoring and control features. By integrating intelligent parking detection with driver communication, Cleverciti enhances data capture and analysis across various organizational divisions. Its solutions have been deployed in diverse sectors such as retail, smart city initiatives, healthcare, and entertainment, all aimed at reducing vehicle emissions, traffic, and improving overall parking management.

BigRep

Series A in 2015
BigRep is a technology start-up based in Berlin with offices in New York, Boston and Singapore, which develops and manufactures the world's largest 3-D printers. One of the groundbreaking developments of the company founded in 2014 is the BigRep ONE, which is supplemented by the smaller BigRep STUDIO. Interdisciplinary and well-founded experience in the field of additive manufacturing characterizes the multi-national team of BigRep, now more than 80 employees. In addition to new products, the Berlin company is now concentrating on complete solutions for industrial customers in the form of integrated additive manufacturing systems. Over the next five years, BigRep intends to become a leading supplier of additive manufacturing systems.

Aquila Biolabs

Seed Round in 2015
aquila biolabs GmbH engages in the development of laboratory devices for the control and analysis of bioprocesses in bioreactors and incubation shakers. Its products include Cell Growth Quantifier (CGQ), Cell Growth Quantifier BIOR (CGQ BIOR), and Liquid Injection System (LIS). The company was founded in 2014 and is based in Baesweiler, Germany.

Sicoya

Series A in 2015
Sicoya GmbH, founded in January 2015 as a spin-off from TU Berlin, specializes in the design, packaging, and sale of application-specific photonic integrated circuits (ASPICs). These ASPICs are available as bare dies or packaged chips, catering primarily to the data center interconnect market. Since its entry into this sector in 2017, Sicoya has developed a 100G transceiver chip that integrates both electronics and optics on a single chip. The company's continuous research and development in silicon photonics, which dates back to 2007, has positioned it to receive initial purchase orders for qualification units and prepare customer samples for major data center players. Sicoya aims to advance high-speed silicon photonics interconnects to facilitate the next generation of internet services. The company is based in Berlin, Germany, and boasts a team of five founders along with a rapidly growing group of experienced professionals.

NEUWAY Pharma

Series A in 2015
NEUWAY Pharma GmbH had been founded in April 2014 as the first spin-off from Life Science Inkubator GmbH. NEUWAY is focusing on the preclinical and clinical development of innovative therapeutics for treatment of orphan brain diseases based on its proprietary CNS drug delivery platform. The company also intends to partner its drug delivery technology for other CNS indications.

Veact

Series A in 2015
VEACT GmbH, founded in 2010 and based in Munich, Germany, specializes in providing software-as-a-service solutions for after-sales marketing in the automotive industry. The company has developed a platform that digitizes marketing processes, utilizing self-learning technology and extensive automobile expertise. By integrating various data sources, such as invoices, service histories, satisfaction surveys, and campaign data, VEACT creates comprehensive customer profiles. This approach allows automotive dealerships and manufacturers to enhance their marketing and sales processes, leading to improved efficiency, reduced costs, and increased customer loyalty. Ultimately, VEACT's services aim to boost revenue for its clients through data-driven insights and predictive customer intelligence.

Biametrics

Series A in 2015
Biametrics specializes in providing innovative research and development services aimed at the academia, pharmaceutical, biotechnology, and diagnostic markets. The company's products focus on label-free detection systems that characterize biomolecular interactions, offering valuable kinetic and thermodynamic data, including affinity measurements and specificity information. Biametrics' technology enables enhanced data evaluation for applications in diagnostics and process analytics, allowing clients to gain insights into biomolecular behavior with unmatched performance in throughput and versatility.

Datapine

Series A in 2015
Datapine is a young innovative company located in the heart of Berlin. They are developing a highly scalable SaaS tool that will revolutionize the way of performing database analysis by making even complex functionalities available to non-technical persons. With their product, they aim to become the innovation leader in the business intelligence market for small and medium-sized companies.

8SELECT

Seed Round in 2015
8select Software GmbH, founded in 2012 and based in Regensburg, Germany, specializes in developing a software-as-a-service (SaaS) solution that enhances online retail through personalized product recommendations. By leveraging interaction, transaction, and profile data from shop visitors, 8select's platform automates the delivery of targeted product suggestions, allowing online shops to offer dynamic and highly tailored recommendations. This approach not only aims to boost customer retention but also enhances overall sales and customer satisfaction for online retailers. As an expert in cross-selling, 8select provides a scalable system that enables clients to effectively personalize their offerings, ultimately driving increased revenue.

Minodes

Seed Round in 2015
Minodes GmbH offers a platform of services for retailers to enhance their offline store performance. Its platform allows retailers to get measures and insights about factors that influence their customer base and in-store revenues; optimize operations, store design, and marketing for every segment of customer base from first time visitors to loyal fans; and launch location-based mobile marketing campaigns to create a new in-store experience. The company was founded in 2013 and is based in Berlin, Germany. As of May 4, 2017, Minodes GmbH operates as a subsidiary of Telefónica Germany NEXT GmbH.

Mandulis Energy

Grant in 2015
Mandulis Energy develops and operates renewable energy projects, with a focus on emerging markets.

OMEICOS Therapeutics

Series A in 2015
OMEICOS Therapeutics GmbH is a biotechnology company focused on developing innovative therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases. Established in 2013 and headquartered in Berlin, Germany, the company is pioneering a first-in-class small molecule that leverages a unique mode of action based on natural metabolites of omega-3 fatty acids. These metabolites exhibit strong anti-arrhythmic properties by activating an endogenous cardio-protective signaling pathway, which not only stabilizes heart rhythm but also aims to provide curative effects by preventing electrical and structural remodeling of the heart. OMEICOS' approach is designed to offer safe and effective treatment options for patients with cardiovascular conditions, while also addressing inflammatory diseases and other indications.

Eskom Holdings

Debt Financing in 2015
Eskom Holdings SOC Ltd is a key player in the electricity sector of South Africa, generating approximately 95% of the country's electricity and around 45% of the electricity consumed in Africa. The company, founded in 1923 and headquartered in Sandton, operates through various segments including Generation, Transmission, and Distribution. It provides electricity to a diverse range of customers, including industrial, mining, commercial, agricultural, and residential sectors. Eskom utilizes multiple energy sources such as coal, nuclear, wind, hydro, and gas turbines for power generation and also engages in electricity trading with countries in the Southern African Development Community (SADC). The company is involved in constructing additional power infrastructure to meet increasing demand and has a service concession for electricity generation and transmission in Uganda. Beyond its core operations, Eskom engages in finance, insurance, corporate social investment, and coal exports, contributing to its broad business portfolio.

GNA Biosolutions

Series B in 2015
GNA Biosolutions is a molecular technology company located in Martinsried, Germany, specializing in innovative diagnostic devices for detecting and analyzing DNA. Their core technology, Pulse Controlled Amplification, enhances molecular testing by integrating ultrafast nucleic acid amplification with intrinsic sample preparation. This advancement allows for efficient and simplified diagnosis of human pathogens in laboratory settings, as well as on-site applications and Point of Care scenarios. GNA Biosolutions aims to make the benefits of molecular testing accessible to a broader audience, facilitating rapid and accurate results from sample collection to analysis.

rankingCoach

Venture Round in 2015
RankingCoach offers small businesses with an application that focuses on online marketing, search engine optimization, and social media. RankingCoach offers businesses with consulting services and support to optimize their websites. It also provides analysis and monitoring tools to monitor websites’ productivity and performance. And it provides businesses with solutions to optimize their digital footprint. RankingCoach provides its services by an annual and monthly contract that requires a subscription fee. RankingCoach was founded in 2011 by Thomas Meierkord, Marius Gerdan, and Daniel Wette. And it is headquartered in Cologne, Germany.

Shelter Afrique

Debt Financing in 2015
Shelter Afrique is a pan-African financial institution established in 1982, dedicated to the development of the housing and real estate sector across Africa. With a partnership of 44 African governments, the African Development Bank, and the Africa Reinsurance Company, it aims to address the needs of the continent's rapidly growing urban population. Shelter Afrique provides a range of financial services including project finance, institutional lending, equity investments, and trade finance, with a focus on facilitating affordable housing and commercial real estate development. Additionally, the organization offers practical advice and technical assistance to various stakeholders in the housing industry, thereby positively impacting the lives of many by supporting efficient housing delivery initiatives.

WeSustain

Series B in 2014
WeSustain is a company based in Buxtehude, Germany, that specializes in web-based software designed for enterprise sustainability management. Founded in 2010, WeSustain's software provides management support that assists organizations in adopting environmentally friendly practices across their products, processes, and technologies. The platform enables clients to implement a comprehensive sustainability management solution, allowing them to measure, improve, and report on their sustainability performance globally while addressing associated risks. Additionally, the software encompasses features such as organizational models, reporting standards, compliance management, and stakeholder surveys, which help enterprises enhance efficiency and effectively communicate their sustainability efforts.

Electrochaea

Series A in 2014
Electrochaea GmbH develops and commercializes a grid-scale power-to-gas energy storage technology. The company’s biocatalytic power-to-gas technology converts low-cost and stranded electricity into pipeline-grade renewable gas for direct injection into the existing natural gas grid, which is used for on-site power production, heating applications, or transmitted over long distances using existing pipelines. Its technology enables storing large amounts of renewable energy from wind and solar; and represents a solution for utility-scale energy storage, grid balancing, and carbon recycling. Electrochaea GmbH was founded in 2010 and is based in Planegg, Germany with additional operation facilities at Hvidovre, Denmark, and Sacramento, California.
Implandata Ophthalmic Products GmbH is a medical device company based in Hanover, Germany, specializing in innovative solutions for the treatment and management of glaucoma. Founded in 2010, the company has developed the Eyemate system, which features an implantable micro sensor designed for continuous intraocular pressure measurement. This technology aims to enhance the monitoring and therapy of glaucoma patients, providing eye care specialists with proactive and personalized guidance in treatment. By integrating advanced medical technology with information systems, Implandata addresses an underserved area in glaucoma care, facilitating more effective management for patients, their families, and healthcare providers.

AYOXXA

Series B in 2014
AYOXXA Biosystems GmbH is a biotechnology company based in Cologne, Germany, with additional offices in Singapore and Boston, Massachusetts. Founded in 2010, AYOXXA specializes in life science tools, particularly through its proprietary technology platform for multiplexed protein analysis. The company has developed an innovative biochip technology that enables the simultaneous measurement of multiple protein markers associated with various health conditions, including cancer, allergies, cardiovascular diseases, and infectious diseases. AYOXXA's platform utilizes an in-situ encoded bead array, facilitating the identification and quantification of proteins and biomolecular analytes. This advanced approach to biomarker analysis positions AYOXXA at the forefront of diagnostic technology, allowing for comprehensive testing in a single assay.

Predict.io

Seed Round in 2014
It is hard to engage app users. Timing is everything. Sending a push in the wrong moment gets you uninstalled. Using smartphone sensors to understand user context is difficult. The company gives developers an SDK that provides user context. The SDK is installed within minutes. It only consumes 0.2% battery per hour. It shows higher accuracy than OS embedded Activity APIs. And it works across platforms iOS, Android, Phonegap. Once activated predict.io constantly reads the sensors (accelerometer, barometer, gyroscope, etc.). The data is pre-processed directly on the device. When a pattern is recognized predict.io fires a "callback"​. The developer can trigger any activity within our outside of his app based on our "callback"​. Once activated we constantly read the sensors (accelerometer, barometer, gyroscope, etc.). We pre-process the data directly on the device. When a pattern is recognized we fire a "callback". The developer can trigger any activity within our outside of his app based on our "callback".

meventi Deutschland

Venture Round in 2014
meventi Deutschland GmbH is a Munich-based company that specializes in advertising and distributing experience gifts and gift ideas for a diverse range of customers, including individuals, couples, and groups. Established in 2007, the company offers a variety of experiences, such as short breaks, helicopter flights, parachute jumps, Ferrari tours, igloo nights, and unique dining experiences like "dinner in the dark." Products are available through its website, a multi-tiered partner program, and integration into customer loyalty systems. In addition to its headquarters in Munich, meventi Deutschland also has branch offices in Sweden.

tixxt

Venture Round in 2014
Tixxt, operated by mixxt GmbH, is a collaboration and communication platform that allows users to create and manage their own social intranet communities effortlessly, without requiring programming skills. The platform is designed to cater to the specific needs of associations, franchises, and corporate groups, facilitating a work and project environment that emphasizes knowledge management and innovation. By offering tools for transparent communication, Tixxt enables organizations to provide employees with quick and clear insights across various domains, enhancing collaboration and productivity within teams.

Streetspotr

Seed Round in 2014
Streetspotr GmbH is a Nürnberg-based company that operates a smartphone application connecting businesses with a mobile workforce across Europe. The application allows companies to post tasks and notify nearby workers, facilitating real-time engagement. Streetspotr specializes in retail intelligence, offering insights into products and promotions within stores, which helps brands and retailers enhance customer experiences and increase sales and profitability. Its services are utilized across various sectors, including business directories, market research, mystery shopping, consumer goods, and retail. In November 2018, Streetspotr was acquired by POSpulse GmbH, further expanding its reach and capabilities in delivering actionable data and insights.

Pflege.de

Series A in 2014
pflege.de, operated by web care LBJ GmbH, is an online portal that provides comprehensive information and resources related to elderly care and housing services in Germany. Founded in 2011 and headquartered in Hamburg, the platform connects users with various health care operators and service providers, offering a diverse range of services. These include nursing and residential care, aids for seniors such as walking and hearing aids, and supportive services like meal delivery and companionship. Additionally, pflege.de emphasizes accessibility by providing solutions like bathroom modifications and stair lifts. The company also offers emergency solutions, including carephones and mobile applications tailored to the needs of the elderly. Through its extensive network of partners, pflege.de aims to deliver holistic care options, ensuring that seniors receive the support they need in both domestic and institutional settings.

smartB

Series A in 2014
smartB Energy Management GmbH, founded in 2014 and based in Berlin, Germany, specializes in software-based energy metering and monitoring solutions for commercial buildings. The company employs advanced non-intrusive technologies and algorithms to provide a comprehensive appliance load monitoring system. By enhancing the transparency of energy usage, smartB enables clients to achieve significant improvements in energy efficiency. Recognizing that commercial buildings consume a substantial portion of the world's energy—accounting for 30% of operational costs—smartB aims to transform sustainability into economic benefits for its customers. Through its innovative approach, the company seeks to challenge the conventional methods of energy management and drive meaningful change within the sector.

flinc

Venture Round in 2014
flinc AG, founded in 2010 and based in Ludwigshafen, Germany, operates a pioneering social mobility network application designed for real-time ridesharing. This platform connects drivers and passengers, facilitating the sharing of everyday rides through a user-friendly interface accessible on desktop and mobile devices. By integrating with navigation technology, flinc allows drivers to navigate directly to passengers without the need for calls or texts, enhancing convenience and safety. The app utilizes an advanced route matching algorithm to efficiently pair users, enabling them to select matches from direct contacts, peer groups, or the broader network. flinc specializes in short- to medium-length journeys, offering solutions for commuters and organizations, including features that integrate public transit schedules, thereby providing a comprehensive transportation alternative. Its innovative approach aims to reduce commuting costs and stress while promoting environmentally-friendly travel options. As of 2017, flinc operates as a subsidiary of moovel GmbH.

Schutzklick

Venture Round in 2013
Schutzklick develops innovative insurance cross-selling solutions for various e-commerce shops to combine traditional insurance with fast-paced digital businesses. The company’s solution enables tailors to cross sell product insurances within their checkout processes. Therefore, online shops are able to monetize their customers twice in one process and gain additional margins and profit. All the company’s products have a fixed life span and are not being extended automatically. The customers pay once and can decided how long the insurance should last. Launched in 2012, the company is headquartered in Germany.

CorTec

Series A in 2013
CorTec GmbH, based in Freiburg, Germany, specializes in neurotechnology, focusing on the measurement and stimulation of brain activity. The company has developed the CorTec Brain Interchange, a brain pacemaker technology designed to treat neurological diseases through an implantable system that can record brain activity and deliver stimulation in a closed-loop manner. This innovative approach enhances the capabilities of physicians in managing neurological conditions and improving patient outcomes. In addition to its primary device, CorTec provides ready-to-use components and custom design solutions tailored to specific client requirements. Founded in 2010, the company is actively involved in advancing neurotherapies, conducting preclinical neuroscientific research, and supporting clinical diagnostics and research efforts.

Capical

Series A in 2013
Capical GmbH is a German company, founded in 2010 and based in Braunschweig, that specializes in the development and marketing of electrocardiography (ECG) devices utilizing capacitive electrodes for contact-free patient monitoring. The company's innovative technology enables high-quality monitoring of heart activity, respiratory rates, and other physiological parameters in various applications, including automotive seating, medical furniture, and occupational settings. Capical has positioned itself as a leader in capacitive electrode technology, recognized for its contributions with multiple awards, including the Fresenius Inventor Award. The company supports clients through all phases of product development, from prototype creation to serial production, aiming to enhance the quality of life for elderly and ill individuals while also improving safety and comfort in automated driving environments. Capical is noted for being the first company to receive medical approval for an ECG device based on capacitive technology and holds significant intellectual property rights to protect its innovations.

Serfides

Seed Round in 2013
SERFIDES develops and sells powerful identity management systems that enable precise, real-time product and component tracking in the logistics process. These systems include tailored consulting services and training courses on process and workflow analyses for supply chains and distribution processes.

Pactas GmbH

Venture Round in 2013
Pactas provides a SaaS platform for recurring billing and subscription management for SaaS and subscription companies, no matter you are a startup or a well established business. Follow us: @pactashq on Twitter | pactas on Facebook

miacosa

Venture Round in 2013
miacosa.de is operated by the Endorsed Goods GmbH. miacosa.de is a social shopping concept from Germany based in Cologne. Social Shopping the miacosa way means that members select their personal shopping team of experts and celebrities that present products they love on miacosa.de Miacosa is for members only. The free service starts with products from the fields of Health Style, Home & Living, Kitchen and fashion accessories.

SIRION BIOTECH

Venture Round in 2013
Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery of new drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing. The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector. The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.

Orpheus GmbH

Series A in 2013
Orpheus is a leading software vendor for spend controls, spend analytics, and transparent strategic procurement. Their AI algorithms and semantic data management enable procurement professionals to recognize hidden bundling and savings potential. Orpheus was founded by Dr. Joerg Dittrich and Michael Lauer in 2005. The company is based in Nuremberg, Germany, and has an office in Mainz. International clients, innovative DAX and MDAX companies as well as large midsize companies utilize their software modules. Contact us to learn more about their references.

ZooRoyal

Venture Round in 2013
ZooRoyal is an online retail platform based in Würselen, Germany, specializing in pet food and supplies. It offers a wide range of products for various pets, including dogs, cats, reptiles, horses, and fish. The company focuses on providing customers with nutritional products and essential accessories, catering to the diverse needs of pet owners. By operating an online shop, ZooRoyal enables convenient access to quality pet care items, ensuring that customers can easily find and purchase the necessary supplies for their pets.

clickworker

Venture Round in 2012
clickworker is an internet platform for paid crowdsourcing. As an innovative service provider, clickworker uses the know-how of qualified Internet users for the flexible and effective processing of business processes that cannot make efficient use of automation, for example in the areas of text creation, SEO texts, web research, tagging and categorization, product data management, surveys, mobile crowdsourcing and translations, Complex tasks are broken into micro jobs by clickworker. These tasks are then made available to the Cickworkers (Internet users registered at www.clickworker.com). The task is converted back into a complete project after successful processing and strict quality inspection.

RegioHelden

Series A in 2012
RegioHelden GmbH, founded in 2010 and headquartered in Stuttgart, Germany, specializes in online marketing services, particularly in search engine optimization. The company aims to assist entrepreneurs, small businesses, and regional companies in leveraging the internet to enhance their visibility and attract customers. By providing search engine marketing software, RegioHelden enables local advertisers to effectively reach their target audience, convert potential clients, and evaluate the success of their marketing campaigns. As of August 2015, RegioHelden operates as a subsidiary of Ströer SE, further solidifying its position in the online marketing landscape.

avandeo

Venture Round in 2012
avandeo, a Munich, Germany- and Shanghai, China-based startup that operates an online destination for designer furniture and home accessories.

Zalando

Debt Financing in 2012
Zalando, founded in Berlin in 2008, is Europe's largest online fashion platform, offering a vast selection of clothing, footwear, accessories, and beauty products for men, women, and children. With nearly 50 million active customers across 25 European countries, Zalando features over 7,000 brands, ranging from renowned international names to local labels. The company's major market is the DACH region, which includes Germany, Austria, and Switzerland. Zalando operates 12 fulfillment centers to ensure efficient logistics and distribution, catering to local customer needs. The platform aims to provide an exceptional online shopping experience by continually optimizing its offerings and leveraging e-commerce expertise.

Orpheus GmbH

Seed Round in 2012
Orpheus is a leading software vendor for spend controls, spend analytics, and transparent strategic procurement. Their AI algorithms and semantic data management enable procurement professionals to recognize hidden bundling and savings potential. Orpheus was founded by Dr. Joerg Dittrich and Michael Lauer in 2005. The company is based in Nuremberg, Germany, and has an office in Mainz. International clients, innovative DAX and MDAX companies as well as large midsize companies utilize their software modules. Contact us to learn more about their references.

GOVECS

Venture Round in 2012
GOVECS, established in 2009, focuses on the development, production, and marketing of electric vehicles, emphasizing clean and efficient transportation solutions. The company is committed to delivering reliable and affordable electric mobility options, with a team of top engineers and designers dedicated to creating stylish zero-emission scooter models. GOVECS aims to be at the forefront of electrical mobility technology, contributing to sustainable transportation solutions.

Augmentation Industries

Seed Round in 2012
Augmentation Industries specializes in developing hardware and an open Vehicle-2-X (V2X) interface that connects vehicles manufactured after 1996 to the internet, allowing access through a smartphone via WiFi. This innovative technology enables crowd developers to create applications for vehicles and provides B2B customers with tools to offer automotive-related services such as insurance, repair, and emergency services. The company's offerings include fully automated driver logs, fleet management solutions, pre-repair diagnostics, and contactless payment systems. Augmentation Industries holds several pending patents that underpin its intellectual property, distinguishing its complete car diagnostic capabilities from competitors. Its unique security concept and RESTful API have garnered positive feedback during presentations. The scalable business model is built on a global standard, facilitating easy deployment across different markets. Initially, the company targets direct sales to B2B clients, such as fleet management and logistics providers, before expanding to B2B2C partnerships with insurance companies and eventually reaching the consumer market.

evidanza

Series C in 2012
evidanza AG is a software provider based in Germany that specializes in business intelligence solutions. Founded in 2001 and headquartered in Regensburg, the company develops software that transforms complex data into actionable insights, facilitating intelligent decision-making for businesses. Its offerings include tools for reporting, planning, OLAP analysis, risk management, cost calculations, and compliance reporting under IFRS and US GAAP standards. By digitizing and optimizing various organizational processes such as accounting, cost accounting, customer relationship management, and corporate planning, evidanza enhances clients' cash flow, cost structures, and overall business models. The company aims to improve operational efficiency and support strategic initiatives through its innovative software solutions.

Customer Alliance

Series B in 2012
Customer Alliance manages and improves hotels online reputations and increase revenue. They collect, analyze, distribute and integrate customer centric data to provide valuable insights for the hotel's operational and strategic decisions. Since officially started in the year of 2009, Customer Alliance has grown to over 5000 customers in 35 countries worldwide. By today, Customer Alliance is a +90 people strong, multinational team coming from various backgrounds on the tourism & hotel industry.

Subitec

Series B in 2012
Subitec was founded in 2000 as a spin-off of the Fraunhofer Institute for Interfacial and Biotechnology (IGB). In the run-up to the founding, scientists at IGB had already been dealing with the subject of microalgae since 1995. In 2007, operational business was started and the first investors were sought after.

Algiax Pharmaceuticals

Series A in 2012
Algiax Pharmaceuticals GmbH is a biotechnology company based in Erkrath, Germany, founded in April 2011. The company specializes in the discovery and development of innovative treatments for nervous system diseases and dysfunctions, with a particular emphasis on neuropathic pain and spinal cord injury. Algiax Pharmaceuticals is focused on creating molecules that inhibit the enzyme dehydroorotate dehydrogenase, which may play a role in managing these conditions. The company has secured 4.3 million euros in Series A financing from a mix of private and state-backed investors, underscoring its financial stability and commitment to advancing its research initiatives.

Micropelt

Venture Round in 2012
Micropelt is a startup that emerged from a collaborative project between Infineon Technologies AG and the Fraunhofer Institute for Physical Measurement Techniques in Germany. The company specializes in developing thin film thermoelectric components through semiconductor manufacturing processes. Micropelt focuses on creating energy-harvesting systems that integrate micro-actuators and sensors. Its product offerings include thermoelectric cooling chips and thermoelectric generators designed for various applications, such as chip spot cooling, biomedical devices, heating, ventilation, and air conditioning systems, as well as fiber optics. These innovations aim to facilitate effective temperature management in individual rooms while contributing to CO2 reduction and enhancing user comfort. The company has secured funding from several financial institutions, enabling its growth and development within the thin-film technology sector.

Simplesurance

Seed Round in 2012
Simplesurance GmbH specializes in providing cross-selling software solutions for e-commerce, allowing consumers to purchase insurance at the point of sale during online transactions. Founded in 2012 and headquartered in Berlin, Germany, with an additional office in Tokyo, Japan, the company offers a platform that integrates seamlessly into the checkout processes of online shops, enabling retailers to monetize their customers twice and enhance profit margins. With over 2,000 partners, including prominent e-commerce platforms and electronic manufacturers, Simplesurance combines traditional insurance with digital commerce. Furthermore, it provides a digital broker service that enables customers to manage their insurance policies conveniently through their smartphones in a fully paperless manner.

numares

Venture Round in 2012
numares AG, founded in 2004 and headquartered in Regensburg, Germany, specializes in the development and marketing of software-based test systems for clinical diagnostics and life science research. The company offers an in vitro diagnostic (IVD) system known as AXINON, which utilizes nuclear magnetic resonance (NMR) spectroscopy to analyze metabolomic networks. Through this technology, numares AG provides physicians with valuable insights into patients' disease status. The company employs magnetic group signaling (MGS) technology to enhance its NMR-based diagnostic solutions, focusing on areas such as cardiovascular diseases, nephrology, oncology, and neurology. As a prominent player in commercial NMR analytics in Europe, numares AG is recognized for delivering fast, cost-efficient, and reliable diagnostic services.

Intelligent Apps

Series B in 2012
In 2009 founders Niclaus Mewes and Sven Kuelper launched "mytaxi" - the first taxi app with a direct connection between passenger and driver. mytaxi has grown to the fastest growing taxi-app with more than 7 million downloads and 35.000 connected taxis. mytaxi is available in over 40 German cities as well as Washington, Madrid, Barcelona, Warsaw, Vienna, Graz, Salzburg and Zurich. Investors include T-Venture Holding GmbH (Deutsche Telekom AG), Daimler Mobility Services GmbH (Daimler AG), KfW, e42 GmbH and Lars Hinrichs (Cinco Capital GmbH). mytaxi brings a demand for quality to the taxi service for the first time. Every driver using mytaxi has the ability to become a contractor and build their own client base by consistently providing passengers with good service and earning high customer ratings. Through the given peer-to-peer connection between passenger and driver the whole ordering process becomes very transparent for both. The passenger can not only track the taxi’s arrival in the app but also see which driver is coming. For the driver the cost modell is very attractive as they only pay for a successfully completed trip. The aim of mytaxi is to drive the concept of urban mobility and to further strengthen its position as an international leader in this field. Accordingly to that mytaxi took over the app development services for Daimler Mobility Services GmbH (Daimler AG).

Pflege.de

Venture Round in 2011
pflege.de, operated by web care LBJ GmbH, is an online portal that provides comprehensive information and resources related to elderly care and housing services in Germany. Founded in 2011 and headquartered in Hamburg, the platform connects users with various health care operators and service providers, offering a diverse range of services. These include nursing and residential care, aids for seniors such as walking and hearing aids, and supportive services like meal delivery and companionship. Additionally, pflege.de emphasizes accessibility by providing solutions like bathroom modifications and stair lifts. The company also offers emergency solutions, including carephones and mobile applications tailored to the needs of the elderly. Through its extensive network of partners, pflege.de aims to deliver holistic care options, ensuring that seniors receive the support they need in both domestic and institutional settings.

Zitra

Seed Round in 2011
Zitra is a company focused on transforming the B2B sales landscape by reinventing trade fairs. It offers a comprehensive suite of services tailored for the European market, including fashion management and consultancy. Additionally, Zitra operates B2C online marketplaces and a B2B wholesale structure, enhancing the buying and selling processes for businesses. The company also provides internal marketing, public relations, and logistics services, positioning itself as a versatile partner in the fashion industry and beyond.

Humedics

Series A in 2011
Humedics GmbH, founded in 2009 and based in Berlin, Germany, specializes in the development of a breath analysis device designed to assess liver function in patients suffering from liver failure. The company's key product, the LiMAx test, is a diagnostic system that includes a medical device, breath masks, and a diagnostic drug, enabling clinicians to quantitatively evaluate individual liver function. This technology supports various applications, such as assessing liver function before and after transplantation, planning liver surgeries, and evaluating conditions like liver cirrhosis. By providing rapid and precise measurements at the bedside, LiMAx facilitates informed decision-making for tailored medical treatments, thereby enhancing patient outcomes. The company has successfully used its technology with thousands of patients and is focused on expanding its global operations.

numares

Venture Round in 2011
numares AG, founded in 2004 and headquartered in Regensburg, Germany, specializes in the development and marketing of software-based test systems for clinical diagnostics and life science research. The company offers an in vitro diagnostic (IVD) system known as AXINON, which utilizes nuclear magnetic resonance (NMR) spectroscopy to analyze metabolomic networks. Through this technology, numares AG provides physicians with valuable insights into patients' disease status. The company employs magnetic group signaling (MGS) technology to enhance its NMR-based diagnostic solutions, focusing on areas such as cardiovascular diseases, nephrology, oncology, and neurology. As a prominent player in commercial NMR analytics in Europe, numares AG is recognized for delivering fast, cost-efficient, and reliable diagnostic services.

Apprupt

Series B in 2011
Apprupt operates as a premium performance network specializing in mobile advertising. The company connects advertisers with a broad array of premium publishers, offering targeted solutions for context-driven mobile advertising. Its services include app marketing, mobile website promotion, and premium lead generation through interactive ads such as click-to-call and click-to-email. Additionally, Apprupt has developed a mobile retargeting technology that allows app providers to re-engage users who have previously interacted with their apps. By focusing on value-driven and emotive branding formats, Apprupt aims to enhance the promotion of product and brand messages in the mobile advertising landscape.

Sividon Diagnostics

Private Equity Round in 2011
Sividon Diagnostics GmbH develops a portfolio of treatment-related diagnostic tests. The company specializes in molecular tumor diagnostics. Its portfolio includes ImmunoPredict biomarker test. The company was founded in 2011 and is based in Cologne, Germany. Sividon Diagnostics GmbH operates as a subsidiary of Myriad Services GmbH.
Pay by Shopping is an innovative tool that can be used to reach new customers, increase website traffic, and to raise conversion rates. Available on browser games, via Mobile, and as a Facebook-App, Pay by Shopping enables users to earn virtual currency and items, such as rebates, from a Publisher by shopping at an Advertiser. It drives incremental revenue for Publishers while at the same time serving as a performance marketing tool for online Advertisers. Advertisers gain new customers and see increased sales. Current partnerships include Facebook, OTTO, Zalando, Ubisoft, and Bigpoint. Pay by Shopping is a product of deal united GmbH. The firm is based in Munich with offices in Paris and San Francisco.

NonWoTecc Medical

Series B in 2011
NonWoTecc GmbH was founded with the financial support of High-Tech Gründerfond (HTGF) and Rheinland Venture Capital Fond (RVC) in February of 2007. The goal was to develop a newly designed vascular prosthesis with improved biocompatible and bio-stable properties. NonWoTecc GmbH was one of only seven companies which received a commitment for financial support from HTGF in 2006.

SIRION BIOTECH

Venture Round in 2011
Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery of new drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing. The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector. The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.

Vimecon

Venture Round in 2011
Vimecon GmbH develops and produces laser catheter for the treatment of heart diseases with a focus on Atrial Fibrillation. It also manufactures products for the medical technology and biotechnology; and offers microscopically small catheters, as well as micro materials handling techniques for exact measurement and dosage. In addition, Vimecon GmbH advises various customers from the scholar and industrial research and development. The company was founded in 2005 and is based in Herzogenrath, Germany.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.